| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibacterials, nalidixic acid derivatives | 2584 | 108319-06-8 |
| Dose | Unit | Route |
|---|---|---|
| 0.80 | g | O |
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 4 | Bocci G, Oprea TI, Benet LZ |
| BA (Bioavailability) | 95 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| S (Water solubility) | 0.11 mg/mL | Bocci G, Oprea TI, Benet LZ |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | J01MA05 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE QUINOLONE ANTIBACTERIALS Fluoroquinolones |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000970 | Antineoplastic Agents |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D059005 | Topoisomerase II Inhibitors |
| MeSH PA | D059003 | Topoisomerase Inhibitors |
| CHEBI has role | CHEBI:35441 | antiinfective agents |
| CHEBI has role | CHEBI:36047 | antibacterial drugs |
| CHEBI has role | CHEBI:50750 | inhibitors of type II topoisomerase |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 5.76 | acidic |
| pKa2 | 8.66 | Basic |
| pKa3 | 0.91 | Basic |
None
None
None
| ID | Source |
|---|---|
| 4020512 | VUID |
| N0000148234 | NUI |
| 4020456 | VANDF |
| 4020512 | VANDF |
| C0076075 | UMLSCUI |
| CHEBI:77788 | CHEBI |
| CHEMBL49282 | ChEMBL_ID |
| CHEMBL277100 | ChEMBL_ID |
| CHEMBL2107495 | ChEMBL_ID |
| DB01405 | DRUGBANK_ID |
| C054745 | MESH_SUPPLEMENTAL_RECORD_UI |
| 60021 | PUBCHEM_CID |
| 10866 | IUPHAR_LIGAND_ID |
| 6224 | INN_ID |
| 105784-61-0 | SECONDARY_CAS_RN |
| 1WZ12GTT67 | UNII |
| 295217 | RXNORM |
| 003636 | NDDF |
| 003637 | NDDF |
| 387555009 | SNOMEDCT_US |
| 96091001 | SNOMEDCT_US |
None